Abstract
Despite advances in diagnostic procedures, early detection of pancreatic cancer is still rare in most cases. Therefore, surgical therapy is often performed in advanced cases of invasive ductal adenocarcinoma of the pancreas, and the long-term prognosis is poor. The 5-yr survival rate of pancreatic cancer is reported to be 3.5–25% in Western countries (1–9). The 1993 annual report of registered cases of pancreatic cancer in Japan (10) showed that the 5-yr survival rate was 17.5% after curative surgery, which is much lower than that in other cancers of the gastrointestinal tract. In the early years of the authors’ department, a standard operation was performed only to remove the main tumor; therefore, the resection rate was low and surgical treatment was often noncurative. Reflecting on the poor results, and inspired by Fortner’s report on regional pancreatectomy (11), this department introduced the extended radical Whipple resection in 1978 (12). Depending on the extent of cancer invasion, major vessels including the portal vein, lymph nodes, and nerve plexuses were resected en bloc in order to improve the radicality of surgery. There are now 11 5-yr survivors after trial and error. This paper reports on this operative procedure for invasive ductal adenocarcinoma of the pancreatic head, and the postoperative results achieved in this department.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gudjonsson B. Cancer of the pancreas, 50 years of surgery. Cancer 1987; 50:2284–2303.
Nitecki SS, Sarr MG, Colby TV, and van Deerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1995; 221:59–66.
Wade TP, El-Ghazzawy AG, Virgo KS, and Johnson FE. The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals. Ann Surg 1995; 221:241–246.
Grace PA, Pitt HA, Tompkins RK, DenBeaten L, and Longmire WP, Jr. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 1986; 151:141–149.
Andersen HB, Baden H, Brahe NEB, and Burcharth F. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Cell Surg 1994; 179:545–552.
Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, van Leewen DJ, de Wit LT, Gouma DJ, and Obertop H. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995; 75:2069–2076.
Crist DW, Sitsmann JV, and Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987; 205:358–365.
Fernandez-del Gastillo F, Rattner DW, and Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995; 130:295–300.
Trade M, Schwall G, and Saeger H. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990; 211:447–458.
The Pancreatic Cancer Registry of the Japan Pancreas Society. Annual report of registered cases of pancreatic cancer in Japan (in Japanese), 1993.
Fortner JG. Regional resection of cancer of the pancreas, a new surgical approach. Surgery 1973; 73:307–320.
Hanyu F, Suzuki M, and Imaizumi T. Whipple operation for pancreatic carcinoma: Japanese experience. In: Beger HG, Buchler MW, and Malfertheiner P. (eds), Standards in pancreatic surgery. Springer-Verlag, Berlin, 1993; pp. 646–653.
Japan Pancreas Society. General rules for cancer of the pancreas, (3rd ed.) Kanehara Shuppan, Tokyo (in Japanese), 1986.
Traverso LW and Longmire WP. Presentation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146:959–962.
TNM Atlas. Springer-Verlag, Berlin, 1992; pp. 132–139.
Whipple AO, Parsons WB, and Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935; 102:763–779.
Cattell RB. Resection of the pancreas. Dissection of special problem. Surg Clin North Am 1943; 23:753–766.
Child CGM. Pancreaticojejunostomy and other problems associated pancreas. Ann Surg 1944; 119:845–855.
Moore GE, Sako Y, and Thomas LB. Medical pancreaticoduodenectomy with resection and reanastomosis of the superior mesenteric vein. Surgery 1951; 30:1–4.
McDermott WV Jr. A one-stage pancreatoduodenectomy with resection of the portal vein for carcinoma of the pancreas. Ann Surg 1952; 136:1012–1017.
Nagakawa T, Kurachi M, Konishi K, and Miyazaki I. Translateral retroperitoneal approach in radical surgery for pancreatic carcinoma. Jap J Surg 1982; 12:229–233.
Hanyu F and Imaizumi T. Extended radical surgery for carcinoma of the head of the pancreas. In: Beger HG, Buchler MW, and Schoenberg MH, (eds), Cancer of the pancreas. Universitatsverlag Ulm GmbH, Ulm, 1996; pp. 389–395.
Koeckerrling F, Kessler H, Hermanek P, and Gall FP. The role of lymph node dissection in the treatment of ductal carcinoma of the pancreas. In: Beger HG, Buchler MW, Schoenberg MH (eds), Cancer of the pancreas. Universitatsverlag Ulm GmbH, Ulm, 1996; pp. 403–408.
Ishikawa O, Ohhigashi H, and Imaoka S. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992; 215:231–236.
Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, De Wit LTh, Verbeek PCM, and Gouma DJ. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 1994; 81:1642–1646.
Launois B, Franci J, Bardaxoglou E, Ramee MP, Paul JL, Mallendant Y, and Campoin JP. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg 1993; 17:122–127.
Porter RA. Carcinoma of the pancreaticoduodenal area, operability and choice of procedure. Ann Surg 1958; 148:711–724
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hanyu, F., Imaizumi, T., Suzuki, M., Harada, N., Hatori, T., Fukuda, A. (1998). Extended Radical Whipple Resection for Cancer of the Head of the Pancreas. In: Reber, H.A. (eds) Pancreatic Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1810-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1810-4_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7294-6
Online ISBN: 978-1-4612-1810-4
eBook Packages: Springer Book Archive